| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
800 |
665 |
$122K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
499 |
382 |
$107K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,063 |
1,835 |
$38K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
326 |
281 |
$33K |
| 36415 |
Collection of venous blood by venipuncture |
1,513 |
1,331 |
$30K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,005 |
936 |
$26K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
202 |
51 |
$23K |
| 84443 |
Thyroid stimulating hormone (TSH) |
355 |
344 |
$19K |
| 80053 |
Comprehensive metabolic panel |
659 |
578 |
$14K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
191 |
161 |
$12K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
86 |
83 |
$11K |
| 80076 |
|
346 |
331 |
$9K |
| 80061 |
Lipid panel |
148 |
143 |
$6K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
64 |
55 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
86 |
82 |
$5K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
293 |
277 |
$4K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
38 |
38 |
$4K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
39 |
38 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
198 |
181 |
$4K |
| 87070 |
|
161 |
155 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
77 |
69 |
$2K |
| 81001 |
|
188 |
178 |
$2K |
| 0012A |
|
40 |
40 |
$2K |
| 0011A |
|
38 |
38 |
$2K |
| 84484 |
|
33 |
27 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
26 |
21 |
$998.07 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
39 |
39 |
$981.53 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
27 |
24 |
$474.23 |
| 0064A |
|
13 |
12 |
$402.64 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12 |
12 |
$383.23 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
14 |
14 |
$275.52 |
| 87807 |
|
15 |
15 |
$243.84 |
| 81000 |
|
13 |
12 |
$219.23 |
| 83735 |
|
13 |
12 |
$133.28 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
12 |
12 |
$98.45 |
| 91301 |
|
67 |
67 |
$63.20 |
| 90686 |
|
15 |
15 |
$34.32 |